Skip to main content
Premium Trial:

Request an Annual Quote

GeneProt Becomes Maiden Licensee to OGS Automated-Proteomics Technology

NEW YORK, Feb. 8 - Oxford GlycoSciences on Friday said that GeneProt has licensed a pair of patents to its automated proteomics technology. 

 

The licenses, for US Patents Nos. 6,064,754 and 6,278,794, cover "the use of methods and apparatus for computer-assisted selection and robotic isolation of proteins following two‑dimensional separation," the companies said in a joint statement.

 

Under the terms of the seven-year, non-exclusive agreement, GeneProt, which becomes the first company to license the technologies, will pay OGS an up-front licensing fee of $1 million in cash and equity. The firm will also shell out additional annual payments that will depend on the status of patents in the US, Europe, and Japan. 

 

Other terms of the deal were not disclosed.

 

"This licensing agreement will give GeneProt the freedom to operate under the patents licensed for the provision of proteomics services," the companies said. "No transfer of technology, know-how or trade secrets will occur under the terms of this transaction."

 

On Thursday, UK-based OGS said it has opened a US office that will focus on specialty biopharmaceuticals. The new facility in Bridgewater, NJ, will be home to OGS' commercial team, headed by Lou Ferrari, vice president of global marketing.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.